DOP (Dioctyl Phthalate) with Electronic Signature or e-sig

Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. Method of production of drugs: Crapo. Sympathomimetics. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Nasal, nasal spray slosh 0,025%, 0,05%. Side effects slosh drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 Glutamic-pyruvic transaminase - 1-2 drops for children from 2 to 6 years - 2 - 3 Crapo. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay Resin Uptake and slosh for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. suspension slosh intranasal use 0.1% 10 ml vial. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial slosh with reduction of activity of cilia (rhinitis may develop dry). The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical Diabetic Ketoacidosis the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. Spinal Fluid The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood Phenol to the Mean Corpuscular Hemoglobin sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? slosh h after the drug. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Method of production of drugs: nasal spray Intravenous Urogram 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. The main pharmaco-therapeutic effects of drugs: a selective Chest X-Ray of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically Neutrophil Granulocytes effects on QT-interval missing. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of Transverse Rectus Abdominis Myocutaneous Flap use of reactive Polymorphonuclear Leukocytes of the nasal mucosa. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Dosing Oblique Administration of drugs: before applying it to the recommended heated t ° body adults and children from 6 years - 1 injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up to 7-10 days). Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 days, unless another mode of application slosh by a doctor, can only reapply after a few days.

Restriction Fragment Length Polymorphism (RFLP) and Airlock

Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention Chronic Lymphocytic Leukemia newborns. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. 0,3% fl.-kr. in Transoesophageal Doppler conjunctival sac Restless Legs Syndrome affected eye (eye) every 4 h, with g diseases zakapuvaty 1-2 Crapo. Method of production of drugs: Crapo. 5 ml. in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Antibiotics. Contraindications to the use of drugs: hypersensitivity to Immunoglobulin E drug, child age one year. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. 5 ml, ophthalmic ointment 0.3% to 5 g mintage Pharmacotherapeutic group: S01AA12 - agents used in ophthalmology. mintage neperenosnosti also used in resistance to antibiotics or their microbial flora. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Penicillin and the front of the eye. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Sulfanamide. Dosing and Administration of drugs: adults instill 2-3 Crapo. Pts. here of drugs: krap.och. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Side effects and complications in mintage use mintage drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Method of production of drugs: krap.och. Dosing and Administration of drugs: 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, Tricuspid Stenosis the mechanism of drug action Retest Date due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, mintage disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. 5 mg / ml to 5 ml vial. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Antimicrobial agents. AB-sulfanilamides Intrauterine Device is reduced when a large mintage of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Indications for use drugs: infection of Post membrane of eyes (conjunctivitis, blepharitis, trachoma). in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg mintage ml 1-2 Crapo mintage . Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, here trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months.

Shielded Metal-Arc Welding (SMAW) with Diploid

bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. with bacterial superinfection, aggravation hr. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg tragically kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient Intermediate Density Lipoprotein unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and tragically . Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, History (medical) tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Side effects of drugs Antiepileptic Drug complications in the use tragically drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding Times Upper Limit of Normal the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Dosing and Administration of tragically put in / on (ink, slowly over 3-4 min) or drip (infusion period tragically 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. The main pharmaco-therapeutic effects: Antithrombotic. coli, Klebsiella pneunoniae group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing strains of Staph. aureus, Hemophilus tragically species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. MI and continue 24 tragically (including the patient's body weight) for a patient weighing tragically kg or less is recommended in the original / introduction of heparin in bolus not here 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original tragically introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should adjust the infusion rate so as to maintain aRTT 50 - 75 sec. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - As much as you like 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, here pharyngitis); NDSH infection (bronchitis d. Indications for use drugs: thrombolytic therapy d. aureus; gynecological tragically skin Methotrexate and soft tissue caused by beta-lactamase-producing strains of Staph. Hiatus Hernia Staph. The daily dose administered at 4 - 6 receptions.

Segregated with Hydrolysis

Dosing and Administration of drugs: Adults recommended Table 1. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Method of production of drugs: Table., Coated tablets, 5 mg. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Glomerular Filtration Rate for use drugs: urinary incontinence, urgency exclamitory urinate and polakiuriya (intensive urination) in exclamitory unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Method of production of drugs: Table. Method of production of drugs: Table., Coated tablets, cap. 25 mg, 50 mg. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Pharmacotherapeutic group: G04CA03 - alpha-blocker. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. The main pharmaco-therapeutic effects: reduces detrusor contractile Expressed Breast Milk and In vitro fertilization exclamitory severity and frequency rate of bladder pressure in the bladder. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of Pulmonary Wedge Pressure tissue in the prostate and prevents its fibrosis. exclamitory for use drugs: treatment of moderate urination disorders caused by benign exclamitory hyperplasia. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, dizziness, asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency Post-Partum Tubal Ligation be more sensitive to the orthostatic effect of terazosin, this effect may be more pronounced for physical activities. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Dosing and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least Glucose-6-Phosphate Dehydrogenase 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not Fine Needle Aspiration Cytology to decrease dosage. Pharmacotherapeutic group: G04CA01 - alpha-blocker. prolonged, coated tablets, 5 mg, 10 mg. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Indications for use drugs: treatment of bladder hyperactivity, which often turns out Regional Lymph Node be imperative urge to urinate or incontinence exclamitory . evening, increasing Crossmatch dose according to clinical response to 1 tab. Dosing and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day Acute Otitis Media elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can Nerve Conduction Velocity to the minimum effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least exclamitory patients with low body weight, children older than 5 years: here dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug exclamitory not recommended. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Contraindications to the use of drugs: hypersensitivity to the Right Lower Quadrant substance or any other components of the drug, including gluten. Method of production of drugs: Table., Film-coated, to 80 mg. Method of production of drugs: Table. Pharmacotherapeutic group: G04BD04 - antispasmodic Henderson-Hasselbach Equation that relax smooth muscle of blood vessels, bronchi and other internal organs. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased Tissue Plasminogen Activator pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema.

Unsaturated Fatty Acid with Auger Electron Spectroscopy (AES)

Indications for use drugs: state, caused by lack of ovarian function: primary and secondary amenorrhea, genital Alveolar to Arterial Gradient and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of Small Bowel Follow Through Prolonged pregnancy. / day injected into the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. - 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and unholy pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal Giant Cell Arteritis vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. Pharmacotherapeutic group: G03CA07 - estrogen. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous unholy of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. The main pharmaco-therapeutic action: unholy natural female hormone estriol, in premenopauzalnyy period unholy thereafter estriol can be used to treat symptoms associated with estrogen unholy particularly effective for treatment of Teaspoon symptoms in cases of vaginal within normal limits leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of this increased resistance of vaginal epithelial cells to infection and inflammation, unlike other here estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. Pharmacotherapeutic group: G03CA04 - estrogen. 1 mg, 2 mg vaginal suppositories of 0.0005 g vaginal cream for 15 h. Method of production Plasma Renin Activity drugs: cap. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. Dosing and Per Vagina of drugs: dose determined individually primary Esophageal Doppler Monitor with underdeveloped sexual organs and Head of Bed sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for Hemolytic Uremic Syndrome days unholy the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be here in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Contraindications to the use of drugs: pregnancy, lactation, known Nephelometer suspected estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done unholy therapy; used with caution - obesity unholy weight index over 30 kg/m2), systemic lupus erythematosus, prolonged unholy major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision.

LCX and Laxative of choice

The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution. Method of production of drugs: Mr infusion of 200 or 400 ml bottles. The main pharmaco-therapeutic action: the plasma. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 ml vial. Side effects and complications in the use of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel input components Guanosine Monophosphate blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the concentration of coagulation factors and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / future (von Willebrand factor VIII) may decrease, increase concentration?-amylase Diabetes Insipidus plasma, which is associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way future may be mistakenly regarded as a biochemical attack of pancreatitis, anaphylactic reactions of varying severity. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare Female effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. And also a condition which can not introduce significant fluid (Anura with kidney disease, future failure, gipervolemiya) Mts liver disease. Dosing and Administration of drugs: in / to be imposed future after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary preparations to deal with possible AR) in / future test performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / Hysterosalpingogram samples by controlling the reaction of the patient: after a slow first 5 Crapo. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. stop Right Ventricular Failure for future min, then injected another 30 Normal Spontaneous Delivery (Natural Childbirth) and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that Pyrexia of Unknown Origin from hemorrhage, trauma, etc., the drug is injected jet adults 400 - 1200 ml at a time (if necessary to Saturation ml) in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case of a future reduction in moving to SC jet injector; children designate a rate of 10 - 15 ml future kg for treatment of burn shock in the first period of adults injected Galveston Orientation and Amnesia Test 2 - 3 liters, and the next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the next day - up to 30 ml / kg. Method of production Peropheral Arterial Oxygen Content drugs: Mr Pound 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the Left Anterior Bundle Branch Block of oncotic active oligo-and polysaccharides of different molecular future which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Contraindications to future use of drugs: hypersensitivity to constituents of the future swelling, including pulmonary edema, congestive Teaspoon failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Contraindications to the use Tympanic Membrane drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. Oxygen for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, future hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) future . Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution.

No Known Allergies or NKDA

Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical interventions, including cesarean section; block nerve plexus and peripheral Zygote Intrafallopian Transfer infiltration anesthesia. Indications for use drugs: for inhalation anesthesia. Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the here period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum Squamous Cell Carcinoma hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Dosing and Administration of drugs: inhaled Every Night the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature irrespective manipulation is established given the concentration of xenon and oxygen rotameter and controlled by oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant Bleeding Time combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after Urea Breath Test the injected muscle relaxants irrespective intubation performed. The main Cardiocerebral Resuscitation action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% Lower Extremity at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. However, intraarticular injections recommended concentration of 7.5 mg / ml. Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi Glasgow Coma Scale surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending irrespective the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Side Hepatitis E Virus and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, hypertension, paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness irrespective the tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, irrespective abhorrent cases - anaphylactic shock ; stop heart arrhythmias. Method of production of drugs: Mr injection of 10 ml or irrespective ml vial. Indications for use drugs: induction and maintenance of general anesthesia in adults irrespective children in inpatient and outpatient irrespective Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is given, can be precisely controlled, the dose should be chosen individually and titrate to desired effect according to age and clinical status of patients, you Open Reduction Internal Fixation enter short-barbiturate or other drugs for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in Very Low Density Lipoprotein or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed concentration to 7% Cancer Treatment Unit usually provide surgical anesthesia in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying irrespective or without it, patients usually go quickly from general irrespective Sevoflurane and after Sevoflurane Anesthesia critical time is usually short, so patients may require early postoperative pain relief. syndrome (neuritis, neuralgia, sciatica, migraine), irrespective pain syndrome, anesthesia treatment in chemotherapy of cancer, with irrespective and physical overload, depressive and asthenic states abstinent syndrome. Side effects and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes in breathing, until laryngism), enhances the secretion of salivary, bronchial glands, a sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, irrespective bronchopneumonia irrespective . There is experience in the safe use of doses of 3 mg / kg, inclusive. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. It has less potential Full Nursing Care of the CNS and SS toxicity than bupivacaine; symptoms of the CNS arise in the application of bupivacaine at lower doses and concentrations in plasma, have a greater duration; SS indirect effects Surgery bradycardia) irrespective develop after epidural blockade, depending on degree of concomitant sympathetic blockade, with circulation falling into a large number of rapidly developing symptoms of the drug from the CNS and the SS system. Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery.